Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
ZH: Investigation, Writing review & editing
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
Some patients research the data, see that tirzepatide produces roughly 5 to 7 percentage points more body weight loss on average than semaglutide, and want access to that additional potential
Completion of the main phase of the trials is expected in 2025, and the 52-week extension will continue to October 2026
No patent term extensions were granted because semaglutide's FDA approval timeline didn't qualify for the maximum 5-year extension available under the Hatch-Waxman Act
US$ 27.44
US$ 20.49
US$ 25.47
US$ 24.83
US$ 22.39
US$ 22.04
US$ 20.37
